Skip to main content
Log in

Effects of orange juice on the pharmacokinetics of atenolol

  • Special Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

Fruit juices can significantly change the pharmacokinetics of several drugs. Our objective was to investigate the effect of orange juice on the pharmacokinetics of the beta-blocking agent atenolol.

Methods

In a randomized cross-over study with two phases and a washout of 2 weeks, ten healthy volunteers took either 200 ml orange juice or water thrice daily for 3 days and twice on the fourth day. On the morning of day 3, each subject ingested 50 mg atenolol with an additional amount of either 200 ml orange juice or water. The plasma concentrations of atenolol and the cumulative excretion of atenolol into urine were measured up to 33 h after its dosing. Systolic and diastolic blood pressures and heart rate were recorded in a sitting position before the intake of atenolol and 2, 4, 6, and 10 h after.

Results

Orange juice decreased the mean peak plasma concentration (Cmax) of atenolol by 49% (range 16–59%, P<0.01), and the mean area under the plasma atenolol concentration–time curve (AUC0-33 h) by 40% (range 25–55%, P<0.01). The time of the peak concentration (tmax) and the elimination half-life (t1/2) of atenolol remained unchanged by orange juice. The amount of atenolol excreted into urine was decreased by 38% (range 17–60%, P<0.01), but the renal clearance remained unaltered. The average heart rate was slightly higher during the orange juice+atenolol phase than during the water+atenolol phase.

Conclusions

Orange juice moderately interferes with the gastrointestinal absorption of atenolol. This food–drug interaction can be of clinical significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bailey DG, Spence JD, Munoz C, Arnold JMO (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268–269

    Article  CAS  PubMed  Google Scholar 

  2. Kantola T, Kivistö KT, Neuvonen PJ (1998) Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 63:397–402

    Article  CAS  PubMed  Google Scholar 

  3. Lilja JJ, Kivistö KT, Neuvonen PJ (1998) Grapefruit juice–simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 64:477–483

    Article  CAS  PubMed  Google Scholar 

  4. Kivistö KT, Lilja JJ, Backman JT, Neuvonen PJ (1999) Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride. Clin Pharmacol Ther 66:448–453

    PubMed  Google Scholar 

  5. Hukkinen SK, Varhe A, Olkkola KT, Neuvonen PJ (1995) Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 58:127–131

    Article  CAS  PubMed  Google Scholar 

  6. Lilja JJ, Kivistö KT, Backman JT, Lamberg TS, Neuvonen PJ (1998) Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 64:655–660

    Article  CAS  PubMed  Google Scholar 

  7. Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, Hering U, Bulitta J, Schreiner P, Sorgel F, Fuhr U (2002) Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 71:21–29

    Article  CAS  PubMed  Google Scholar 

  8. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB (1997) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545–2553

    CAS  PubMed  Google Scholar 

  9. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB (2002) Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71:11–20

    Article  CAS  PubMed  Google Scholar 

  10. Lilja JJ, Backman JT, Laitila J, Luurila H, Neuvonen PJ (2003) Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol. Clin Pharmacol Ther 73:192–198

    Article  CAS  PubMed  Google Scholar 

  11. Lilja JJ, Juntti-Patinen L, Neuvonen PJ (2004) Orange juice substantially reduces the bioavailability of the beta-adrenergic-blocking agent celiprolol. Clin Pharmacol Ther 75:184–190

    Article  CAS  PubMed  Google Scholar 

  12. Dollery C (ed) (1999) Therapeutic drugs. vol 1. Churchill Livingstone, Edinburgh, UK, pp A224–A227

    Google Scholar 

  13. Wan SH, Koda RT, Maronde RF (1979) Pharmacokinetics, pharmacology of atenolol and effect of renal disease. Br J Clin Pharmacol 7:569–574

    CAS  PubMed  Google Scholar 

  14. Karlsson J, Kuo S-M, Ziemniak J, Artursson P (1993) Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Br J Pharmacol 110:1009–1016

    CAS  PubMed  Google Scholar 

  15. Läer S, Wauer I, Scholz H (2001) Small blood volumes from children for quantitative sotalol determination using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 753:421–425

    Article  PubMed  Google Scholar 

  16. Yee GC, Stanley DL, Pessa LJ, Dalla Costa T, Beltz SE, Ruiz J, Lowenthal DT (1995) Effect of grapefruit juice on blood cyclosporin concentration. Lancet 345:955–956

    Article  CAS  PubMed  Google Scholar 

  17. Artursson P (1990) Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79:476–482

    CAS  PubMed  Google Scholar 

  18. Lennernäs H, Ahrenstedt Ö, Ungell A-L (1994) Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat. Br J Clin Pharmacol 37:589–596

    PubMed  Google Scholar 

  19. Melander A, Stenberg P, Liedholm H, Scherstén B, Wåhlin-Boll E (1979) Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol 16:327–330

    Article  CAS  PubMed  Google Scholar 

  20. Barnwell SG, Laudanski T, Dwyer M, Story MJ, Guard P, Cole S, Attwood D (1993) Reduced bioavailability of atenolol in man: the role of bile acids. Int J Pharm 89:245–250

    Article  CAS  Google Scholar 

  21. Yamaguchi T, Ikeda C, Sekine Y (1986) Intestinal absorption of a beta-adrenergic blocking agent nadolol. II. Mechanism of the inhibitory effect on the intestinal absorption of nadolol by sodium cholate in rats. Chem Pharm Bull 34:3836–3843

    CAS  PubMed  Google Scholar 

  22. Yamaguchi T, Oida T, Ikeda C (1986) Intestinal absorption of a beta-adrenergic blocking agent nadolol. III. Nuclear magnetic resonance spectroscopic study on nadolol-sodium cholate micellar complex and intestinal absorption of nadolol derivatives in rats. Chem Pharm Bull 34:4259–4264

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mrs. Eija Mäkinen-Pulli, Mrs. Lisbet Partanen, and Mr. Jouko Laitila for technical assistance and determination of drug concentrations. This study complies with the current laws of Finland. This study was supported by grants from the Helsinki University Central Hospital Research Fund.

Conflict of interest:

No information supplied

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. J. Lilja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lilja, J.J., Raaska, K. & Neuvonen, P.J. Effects of orange juice on the pharmacokinetics of atenolol. Eur J Clin Pharmacol 61, 337–340 (2005). https://doi.org/10.1007/s00228-005-0930-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0930-9

Keywords

Navigation